Free Trial

InnoCare Pharma (INCPF) Short Interest Ratio & Short Volume

$3.26 0.00 (0.00%)
As of 06/20/2025

InnoCare Pharma Short Interest Data

InnoCare Pharma (INCPF) has a short interest of 747,000 shares. This marks a -33.15% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 3,450 shares to cover all short positions.

Current Short Interest
747,000 shares
Previous Short Interest
1,117,400 shares
Change Vs. Previous Month
-33.15%
Dollar Volume Sold Short
$2.44 million
Short Interest Ratio
0.0 Days to Cover
Last Record Date
May 31, 2025
Today's Trading Volume
0 shares
Average Trading Volume
3,450 shares
Today's Volume Vs. Average
0%
Short Selling InnoCare Pharma?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for InnoCare Pharma and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

INCPF Short Interest Over Time

INCPF Days to Cover Over Time

INCPF Percentage of Float Shorted Over Time

InnoCare Pharma Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/31/2025747,000 shares $2.44 million -33.2%N/A0 $3.26
5/15/20251,117,400 shares $3.64 million -34.3%N/A0 $3.26
4/30/20251,701,000 shares $5.55 million -22.2%N/A0 $3.26
4/15/20252,186,000 shares $7.13 million -0.6%N/A0 $3.26
3/31/20252,198,000 shares $7.17 million +28.5%N/A0 $3.26
3/15/20251,710,000 shares $5.57 million -43.9%N/A0 $3.26
2/28/20253,046,000 shares $9.93 million -10.4%N/A371.5 $3.26
2/15/20253,399,000 shares $11.08 million +0.8%N/A0 $3.26
1/31/20253,373,000 shares $11.00 million +1.1%N/A0 $3.26
1/15/20253,338,000 shares $10.88 million +1.3%N/A0 $3.26
12/31/20243,295,000 shares $10.74 million -11.1%N/A0 $3.26
12/15/20243,707,000 shares $12.08 million +11.3%N/A0 $3.26
11/30/20243,330,000 shares $10.86 million +1.0%N/A0 $3.26
11/15/20243,297,000 shares $10.75 million +0.1%N/A0 $3.26
10/31/20243,294,000 shares $10.74 million No ChangeN/A0 $3.26
10/15/20243,294,000 shares $10.74 million No ChangeN/A0 $3.26
9/30/20243,294,000 shares $10.74 million No ChangeN/A0 $3.26
9/15/20243,294,000 shares $10.74 million -0.5%N/A0 $3.26
8/31/20243,311,000 shares $10.79 million No ChangeN/A0 $3.26
8/15/20243,311,000 shares $10.79 million No ChangeN/A0 $3.26
7/31/20243,311,000 shares $10.79 million No ChangeN/A0 $3.26
7/15/20243,311,000 shares $10.79 million No ChangeN/A0 $3.26
6/30/20243,311,000 shares $10.79 million +6.9%N/A0 $3.26
6/15/20243,096,000 shares $10.09 million +8.0%N/A0 $3.26
5/31/20242,868,000 shares $9.35 million No ChangeN/A0 $3.26
5/15/20242,868,000 shares $9.35 million -2.1%N/A0 $3.26
4/30/20242,929,400 shares $9.55 million -0.5%N/A0 $3.26
4/15/20242,943,400 shares $9.60 million +8.4%N/A0 $3.26
3/31/20242,714,400 shares $8.85 million -10.0%N/A0 $3.26
3/15/20243,017,400 shares $9.84 million -10.2%N/A0 $3.26
2/29/20243,359,400 shares $10.95 million -1.0%N/A0 $3.26
2/15/20243,392,400 shares $11.06 million -1.5%N/A0 $3.26
1/15/20243,509,400 shares $11.44 million -2.5%N/A0 $3.26
12/31/20233,600,000 shares $11.74 million -0.8%N/A0 $3.26
12/15/20233,629,000 shares $11.83 million +93.2%N/A1649.5 $3.26
11/30/20231,878,000 shares $6.12 million +14.9%N/A0 $3.26
11/15/20231,634,400 shares $5.33 million -3.7%N/A0 $3.26
10/31/20231,697,400 shares $5.53 million No ChangeN/A0 $3.26
10/15/20231,697,400 shares $5.53 million No ChangeN/A0 $3.26
9/30/20231,697,400 shares $5.53 million -0.4%N/A0 $3.26
3..2..1.. AI 2.0 ignition (don’t sleep on this) (Ad)

I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.

Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave.
9/15/20231,703,400 shares $5.55 million No ChangeN/A0 $3.26
8/31/20231,703,400 shares $5.55 million -24.3%N/A0 $3.26
8/15/20232,249,400 shares $7.33 million -0.7%N/A0 $3.26
7/31/20232,265,400 shares $7.39 million +6.5%N/A0 $3.26
7/15/20232,126,400 shares $6.93 million +31.4%N/A0 $3.26
6/30/20231,618,400 shares $5.28 million +39.8%N/A0 $3.26
6/15/20231,157,400 shares $3.77 million +25.5%N/A0 $3.26
5/31/2023922,400 shares $3.01 million +3.4%N/A0 $3.26
5/15/2023892,400 shares $2.91 million +9.5%N/A0 $3.26
4/30/2023815,000 shares $0.00 +59.2%N/A0 $0.00

INCPF Short Interest - Frequently Asked Questions

What is InnoCare Pharma's current short interest?

Short interest is the volume of InnoCare Pharma shares that have been sold short but have not yet been closed out or covered. As of May 31st, traders have sold 747,000 shares of INCPF short. Learn More on InnoCare Pharma's current short interest.

Is InnoCare Pharma's short interest increasing or decreasing?

InnoCare Pharma saw a drop in short interest in May. As of May 31st, there was short interest totaling 747,000 shares, a drop of 33.1% from the previous total of 1,117,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), MicroStrategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks.

What does it mean to sell short InnoCare Pharma stock?

Short selling INCPF is an investing strategy that aims to generate trading profit from InnoCare Pharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against InnoCare Pharma?

A short squeeze for InnoCare Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INCPF, which in turn drives the price of the stock up even further.

How often is InnoCare Pharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INCPF, twice per month. The most recent reporting period available is May, 31 2025.




This page (OTCMKTS:INCPF) was last updated on 6/22/2025 by MarketBeat.com Staff
From Our Partners